Get started
Author

Luca Vincenzo Cappelli

Observed names: Cappelli LV, L. V. Cappelli, L.V. Cappelli, Luca Vincenzo Cappelli, Luca Cappelli, Luca V. Cappelli
Observed institutions: NewYork–Presbyterian Hospital, Cornell University, Policlinico Umberto I, Munich Leukemia Laboratory (Germany), Weill Cornell Medicine, Sapienza University of Rome
ORCID: 0000-0001-8090-3880
Observed ORCID: 0000-0001-8090-3880
OpenAlex ID: A5031563326
Peripheral T cell lymphomas: from the bench to the clinic
2020 · Danilo Fiore, Luca Vincenzo Cappelli, et al. · Nature reviews. Cancer · 126
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
2020 · André F. Rendeiro, Joseph Casano, et al. · Life Science Alliance · 80
PDF
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
2019 · Ilaria Del Giudice, Sara Raponi, et al. · Frontiers in Oncology · 56
PDF
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
2021 · Luca Vincenzo Cappelli, Manja Meggendorfer, et al. · Leukemia · 45
PDF
Comparative analysis between RQ ‐ PCR and digital droplet PCR of BCL 2/ IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma
2017 · Marzia Cavalli, Lucia Anna De Novi, et al. · British Journal of Haematology · 43
IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies
2018 · Manja Meggendorfer, Luca Vincenzo Cappelli, et al. · Leukemia · 40
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia
2021 · Maria Cristina Puzzolo, Ilaria Del Giudice, et al. · Frontiers in Oncology · 30
PDF
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis
2021 · Juan F. Linares, Xiao Zhang, et al. · Molecular Cell · 27
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
2020 · Sara Raponi, Caterina Ilari, et al. · British Journal of Haematology · 23
PDF
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
2022 · André F. Rendeiro, Charles Kyriakos Vorkas, et al. · Frontiers in Immunology · 21
PDF
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy
2019 · Alessandro Pulsoni, Irene Della Starza, et al. · British Journal of Haematology · 21
PDF
DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern
2019 · Luca Vincenzo Cappelli, Manja Meggendorfer, et al. · Leukemia · 20
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries
2020 · Danilo Fiore, Luca Vincenzo Cappelli, et al. · Cancers · 18
PDF
Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities
2022 · Luca Vincenzo Cappelli, Danilo Fiore, et al. · Blood · 17
PDF
Biallelic BIRC 3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
2018 · Sara Raponi, Ilaria Del Giudice, et al. · British Journal of Haematology · 13
PDF
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
2023 · Alberto Quattrocchi, Luca Vincenzo Cappelli, et al. · Aspects of Molecular Medicine · 12
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia
2022 · Irene Della Starza, Lucia A. De Novi, et al. · Journal of Molecular Diagnostics · 11
PDF
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
2025 · Danilo Fiore, Luca Vincenzo Cappelli, et al. · Cell Reports Medicine · 10
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation
2026 · Chiara Cosentino, Samir Mouhssine, et al. · HemaSphere · 9
PDF
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia
2021 · Luciana Cafforio, Sara Raponi, et al. · Haematologica · 9
PDF
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma
2025 · Alyssa Bouska, Weiwei Zhang, et al. · American Journal of Hematology · 7
In Vivo and Ex Vivo Patient‐Derived Tumor Xenograft Models of Lymphoma for Drug Discovery
2021 · Maria Teresa Cacciapuoti, Luca Vincenzo Cappelli, et al. · Current Protocols · 6
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study
2023 · Francesco Malfona, Ilaria Tanasi, et al. · Haematologica · 3
PDF
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature
2023 · Ilaria Del Giudice, Luca Vincenzo Cappelli, et al. · British Journal of Haematology · 3
PDF
Early Stage Follicular Lymphoma. Predictive Role of Minimal Residual Disease (MRD) and Impact of MRD-Driven Treatment with Radiotherapy and Rituximab on Clinical Outcome
2016 · Alessandro Pulsoni, Irene Della Starza, et al. · Blood · 3
Works count: 56
Citation count: 667
H-index: 14
I10-index: 18
Year
Topic
Type